CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-12 | Meiers James R. Head of Canada | Option exercise | +32,548 | 32,548 | ||
| 2021-08-12 | Meiers James R. Head of Canada | Shares withheld for taxes | −7,926 | $14.10 | $112K | 24,622 |
| 2021-08-12 | Meiers James R. Head of Canada | Option exercise · Restricted Stock Units | −32,548 | 32,548 | ||
| 2021-08-12 | SIMON IRWIN D President and CEO | Option exercise | +180,251 | 563,385 | ||
| 2021-08-12 | SIMON IRWIN D President and CEO | Shares withheld for taxes | −90,126 | $14.10 | $1.3M | 473,259 |
| 2021-08-12 | SIMON IRWIN D President and CEO | Option exercise · Restricted Stock Units | −180,251 | 180,251 | ||
| 2021-08-12 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +26,443 | 46,960 | ||
| 2021-08-12 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −9,163 | $14.10 | $129K | 37,797 |
| 2021-08-12 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Restricted Stock Units | −26,443 | 26,444 | ||
| 2021-08-07 | SIMON IRWIN D President and CEO | Option exercise | +25,852 | 396,060 | ||
| 2021-08-07 | SIMON IRWIN D President and CEO | Shares withheld for taxes | −12,926 | $14.42 | $186K | 383,134 |
| 2021-08-07 | SIMON IRWIN D President and CEO | Option exercise · Restricted Stock Units | +25,852 | 0 | ||
| 2021-08-05 | Kennedy Brendan Director | Sale | −300,000 | $14.46 | $4.3M | 7,974,196 |
| 2021-08-04 | Kennedy Brendan Director | Sale | −300,000 | $14.08 | $4.2M | 8,274,196 |
| 2021-07-27 | SIMON IRWIN D President and CEO | Grant or award · Performance-Based Restricted Stock Units | +392,772 | 392,772 | ||
| 2021-07-27 | SIMON IRWIN D President and CEO | Grant or award · Restricted Stock Units | +392,772 | 392,772 | ||
| 2021-07-27 | SIMON IRWIN D President and CEO | Grant or award · Performance-Based Restricted Stock Units | +392,772 | 392,772 | ||
| 2021-07-27 | SIMON IRWIN D President and CEO | Grant or award · Restricted Stock Units | +189,781 | 189,781 | ||
| 2021-07-26 | Merton Carl A Chief Financial Officer | Grant or award · Performance-Based Restricted Stock Units | +48,662 | 48,662 | ||
| 2021-07-26 | Merton Carl A Chief Financial Officer | Grant or award · Restricted Stock Units | +48,661 | 48,661 |
Page 23 of 35 · 686 trades